(Q44428923)

2 December 2017

title

Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers (English)

1 reference

2 December 2017

Nitration inhibits fibrillation of human α‐synuclein in vitro by formation of soluble oligomers (English)

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(03)00367-3

30 December 2023

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(03)00367-3

30 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(03)00367-3

30 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(03)00367-3

30 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(03)00367-3

30 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(03)00367-3

30 December 2023

2

Vladimir N Uversky

1 reference

2 December 2017

Ghiam Yamin

1

1 reference

2 December 2017

Vladimir N. Uversky

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12729915

30 December 2023

Anthony L. Fink

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12729915

30 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

2 December 2017

8 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12729915

full work available at URL

30 December 2023

https://febs.onlinelibrary.wiley.com/doi/pdfdirect/10.1016/S0014-5793%2803%2900367-3

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12729915

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2FS0014-5793%2803%2900367-3

30 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(03)00367-3

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2FS0014-5793(03)00367-3

30 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(03)00367-3

https://febs.onlinelibrary.wiley.com/doi/pdf/10.1016/S0014-5793%2803%2900367-3

30 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(03)00367-3

30 December 2023

1 reference

2 December 2017

volume

542

1 reference

2 December 2017

issue

1-3

1 reference

2 December 2017

page(s)

147-152

1 reference

Alpha-synuclein in Lewy bodies

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

A Drosophila model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Evidence for a partially folded intermediate in alpha-synuclein fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Cell biology. The importance of being unfolded.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Conformational properties of alpha-synuclein in its free and lipid-associated states

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Intrinsically disordered protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

The protein trinity--linking function and disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Insights into the structure and dynamics of unfolded proteins from nuclear magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Intrinsic disorder and protein function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Synthetic filaments assembled from C-terminally truncated alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Neurodegenerative disease: amyloid pores from pathogenic mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

The biophysics of sickle cell hydroxyurea therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Induction of alpha-synuclein aggregation by intracellular nitrative insult.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Tetranitromethane. A Reagent for the Nitration of Tyrosyl Residues in Proteins*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Modification of a specific tyrosine enables tracing of the end‐to‐end distance during apomyoglobin folding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

Neuropathology of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900367-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Protein measurement with the Folin phenol reagent

series ordinal

35

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(03)00367-3

30 December 2023

Identifiers

1 reference

release_5js4jgcpi5bujfnbzq5i5grasu

2 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5js4jgcpi5bujfnbzq5i5grasu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference